Rexford Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
1,656
+68
+4% +$68.9K 1.09% 20
2025
Q4
$1.71M Buy
1,588
+5
+0.3% +$4.78K 1.29% 13
2025
Q3
$1.21M Buy
1,583
+95
+6% +$70.7K 0.93% 21
2025
Q2
$1.16M Buy
+1,488
New +$1.16M 0.96% 20

Other funds holding LLY

Rexford Capital's LLY Position: Q1 2026 in Review

Rexford Capital increased its Eli Lilly (LLY) stake by 4.3% in Q1 2026, buying an estimated $68.9K and bringing the position to 1,656 shares worth $1.52M. The position accounts for 1.09% of the portfolio, ranked #20.

Rexford Capital first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.71M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Rexford Capital held 1,656 shares of Eli Lilly worth $1.52M as of Q1 2026.
  • Rexford Capital bought 68 Eli Lilly shares in Q1 2026, an estimated $68.9K.
  • Eli Lilly made up 1.09% of Rexford Capital's portfolio in Q1 2026, its #20 holding.
  • Rexford Capital first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Rexford Capital's Eli Lilly position peaked at $1.71M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.